North America Gene Amplification Technologies Market Size & Outlook

The gene amplification technologies market in North America is expected to reach a projected revenue of US$ 11,424.4 million by 2028. A compound annual growth rate of -0.7% is expected of North America gene amplification technologies market from 2022 to 2028.

Revenue, 2021 (US$M)
$12,025.5
Forecast, 2028 (US$M)
$11,424.4
CAGR, 2022 - 2028
-0.7%
Report Coverage
North America

North America gene amplification technologies market highlights

  • The North America gene amplification technologies market generated a revenue of USD 12,025.5 million in 2021.
  • The market is expected to grow at a CAGR of -0.7% from 2022 to 2028.
  • In terms of segment, pcr-based amplification was the largest revenue generating technology in 2021.
  • Loop Mediated Isothermal Amplification (LAMP) is the most lucrative technology segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2022 to 2028.


North America data book summary

Market revenue in 2021USD 12,025.5 million
Market revenue in 2028USD 11,424.4 million
Growth rate-0.7% (CAGR from 2021 to 2028)
Largest segmentPcr-based amplification
Fastest growing segmentLoop Mediated Isothermal Amplification (LAMP)
Historical data covered2018 - 2020
Base year for estimation2021
Forecast period covered2022 - 2028
Quantitative unitsRevenue in USD million
Market segmentationPCR-based Amplification, Loop Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA), Strand Displacement Amplification (SDA), Multiple displacement amplification (MDA), Rolling Circle Amplification (RCA), Ramification amplification method (RAM)
Key market players worldwideQiagen NV, Illumina Inc, Bio-Rad Laboratories Inc, Silicon Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, Danaher Corp, New England Biolabs, 4Basebio, LGC Group, Vazyme Biotech, MyBiosource


Other key industry trends

  • In terms of revenue, North America region accounted for 37.4% of the global gene amplification technologies market in 2021.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2028.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 8,409.9 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Gene Amplification Technologies Market Companies

Name Profile # Employees HQ Website

North America gene amplification technologies market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene amplification technologies market will help companies and investors design strategic landscapes.


Pcr-based amplification was the largest segment with a revenue share of 90.63% in 2021. Horizon Databook has segmented the North America gene amplification technologies market based on pcr-based amplification, loop mediated isothermal amplification (lamp), nucleic acid sequence based amplification (nasba), strand displacement amplification (sda), multiple displacement amplification (mda), rolling circle amplification (rca), ramification amplification method (ram) covering the revenue growth of each sub-segment from 2018 to 2028.


North America leads the gene amplification technologies market due to strong genomics, proteomics, oncology, and diagnostic space in the region. The region is also a home to a large number of market players and service providers that are constantly engaged in the development of advanced amplification technologies.

The presence of innovators and key market players has resulted in increasing penetration of market products in the region. These players offer products specific to different applications such as whole genome sequencing, exome sequencing and others with different features.

Owing to the recent outbreak of SARS-CoV-2 virus, several players in the region have developed amplification based rapid tests to combat the disease. This has resulted in increasing adoption of these products in the market.

Reasons to subscribe to North America gene amplification technologies market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America gene amplification technologies market databook

  • Our clientele includes a mix of gene amplification technologies market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America gene amplification technologies market , including forecasts for subscribers. This continent databook contains high-level insights into North America gene amplification technologies market from 2018 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America gene amplification technologies market size, by country, 2018-2028 (US$M)

North America Gene Amplification Technologies Market Outlook Share, 2021 & 2028 (US$M)

North America gene amplification technologies market size, by country, 2018-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more